1. Tan, Siyu, Wang, Zehua, Li, Na, Liang, Xiaohong, Ma, Chunhong. 2023. Transcription factor Zhx2 is a checkpoint that programs macrophage polarization and antitumor response. In Cell death and differentiation, 30, 2104-2119. doi:10.1038/s41418-023-01202-4. https://pubmed.ncbi.nlm.nih.gov/37582865/
2. Beierle, Jacob A, Yao, Emily J, Goldstein, Stanley I, Ferris, Martin T, Bryant, Camron D. 2022. Zhx2 Is a Candidate Gene Underlying Oxymorphone Metabolite Brain Concentration Associated with State-Dependent Oxycodone Reward. In The Journal of pharmacology and experimental therapeutics, 382, 167-180. doi:10.1124/jpet.122.001217. https://pubmed.ncbi.nlm.nih.gov/35688478/
3. Zhang, Yankun, Fan, Yuchen, Hu, Huili, Yue, Xuetian, Ma, Chunhong. 2023. ZHX2 emerges as a negative regulator of mitochondrial oxidative phosphorylation during acute liver injury. In Nature communications, 14, 7527. doi:10.1038/s41467-023-43439-0. https://pubmed.ncbi.nlm.nih.gov/37980429/
4. Zhang, Jing, Wu, Tao, Simon, Jeremy, Baldwin, Albert S, Zhang, Qing. . VHL substrate transcription factor ZHX2 as an oncogenic driver in clear cell renal cell carcinoma. In Science (New York, N.Y.), 361, 290-295. doi:10.1126/science.aap8411. https://pubmed.ncbi.nlm.nih.gov/30026228/
5. Nagel, Stefan, Schneider, Björn, Meyer, Corinna, Drexler, Hans G, Macleod, Roderick A F. 2011. Transcriptional deregulation of homeobox gene ZHX2 in Hodgkin lymphoma. In Leukemia research, 36, 646-55. doi:10.1016/j.leukres.2011.10.019. https://pubmed.ncbi.nlm.nih.gov/22078940/